Contribution of pharmacogenetics
| Affiliation auteurs | Affiliation ok |
| Titre | Contribution of pharmacogenetics |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Masse C, Vandel P |
| Journal | ANNALES MEDICO-PSYCHOLOGIQUES |
| Volume | 174 |
| Pagination | 53-56 |
| Date Published | JAN |
| Type of Article | Article |
| ISSN | 0003-4487 |
| Mots-clés | Drug interaction, Drug therapy, Efficiency, Genetic, Genome, pharmacology, Psychotropic, Side effect |
| Résumé | Since the 1950s, the aim of pharmacogenetics has been dedicated to improve therapeutic strategies in particular on psychiatric diseases. Though pharmacological treatment is still hampered by a delayed time of onset of clinical improvement and a series of side effects. One of the tools for this tailored medication is the use of pharmacogenetics, leading to an evaluation of the human genome implications in the treatment response. The results are promising but more researches are needed to include pharmacogenetics studies in the clinical practice and personalize medicine in neuropsychiatry. (C) 2016 Elsevier Masson SAS. All rights reserved. |
| DOI | 10.1016/j.amp.2015.12.008 |